General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

ADR voting center

For holders of American Depositary Receipts (ADRs) of Novartis AG

Notice of Annual General Meeting

The Novartis Annual General Meeting 2014 will take place on February 25, 2014 in Basel, Switzerland.

Annual Report 2013

Annual Report 2012 cover

Review the strategy and annual performance of Novartis.


Find further information on our Corporate Governance

ADR voting for Employee Plan participants

If you obtained your ADRs through an Employee Plan, click the appropriate link below and follow the directions provided.


If you obtained your ADRs outside of an Employee Plan, follow the intructions below.

ADR voting for holders registered with the depositary

If you hold ADRs directly registered with the depositary please click the link below and follow the directions provided.

ADR Registered Holder

ADR voting through a broker

If you hold ADRs beneficially through a broker, you must follow the instructions and use a voting card and the process provided by your broker.

Stock chart
Q3 Results 2013

On Thursday, April 24, Novartis will announce its results for the first quarter of 2014